{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:45:00Z","timestamp":1777182300460,"version":"3.51.4"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100021080","name":"Creutzfeldt-Jakob Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["p19050"],"award-info":[{"award-number":["p19050"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017519","name":"Werner Otto Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC877 \u201cProteolysis as a regulatory event in pathophysiology\u201d project A12"],"award-info":[{"award-number":["CRC877 \u201cProteolysis as a regulatory event in pathophysiology\u201d project A12"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Munich Cluster for Systems Neurology (EXC 2145 SyNergy"],"award-info":[{"award-number":["Munich Cluster for Systems Neurology (EXC 2145 SyNergy"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ID 390857198)"],"award-info":[{"award-number":["ID 390857198)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TA 167\/6-3"],"award-info":[{"award-number":["TA 167\/6-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2033 - 390677874 \u2013 RESOLV"],"award-info":[{"award-number":["EXC 2033 - 390677874 \u2013 RESOLV"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHA 2248\/2-1"],"award-info":[{"award-number":["SCHA 2248\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["grant #202108080249"],"award-info":[{"award-number":["grant #202108080249"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Slovene Research Agency","award":["grant number: L3-3435"],"award-info":[{"award-number":["grant number: L3-3435"]}]},{"name":"Slovene Research Agency","award":["grant number: L3-6006"],"award-info":[{"award-number":["grant number: L3-6006"]}]},{"name":"Slovene Research Agency","award":["grant number: L3-0206"],"award-info":[{"award-number":["grant number: L3-0206"]}]},{"name":"Slovene Research Agency","award":["grant number: P4-0176"],"award-info":[{"award-number":["grant number: P4-0176"]}]},{"name":"Slovene Research Agency","award":["grant number: P3-0171"],"award-info":[{"award-number":["grant number: P3-0171"]}]},{"name":"Slovene Research Agency","award":["PhD student funding"],"award-info":[{"award-number":["PhD student funding"]}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["Marie Sk\u0142odowska Curie grant #101030402"],"award-info":[{"award-number":["Marie Sk\u0142odowska Curie grant #101030402"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Proteolytic cell surface release (\u2018shedding\u2019) of the prion protein (PrP), a broadly expressed GPI-anchored glycoprotein, by the metalloprotease ADAM10 impacts on neurodegenerative and other diseases in animal and in vitro models. Recent studies employing the latter also suggest shed PrP (sPrP) to be a ligand in intercellular communication and critically involved in PrP-associated physiological tasks. Although expectedly an evolutionary conserved event, and while soluble forms of PrP are present in human tissues and body fluids, for the human body neither proteolytic PrP shedding and its cleavage site nor involvement of ADAM10 or the biological relevance of this process have been demonstrated thus far. In this study, cleavage site prediction and generation (plus detailed characterization) of sPrP-specific antibodies enabled us to identify PrP cleaved at tyrosin 226 as the physiological and apparently strictly ADAM10-dependent shed form in humans. Using cell lines, neural stem cells and brain organoids, we show that shedding of human PrP can be stimulated by PrP-binding ligands without targeting the protease, which may open novel therapeutic perspectives. Site-specific antibodies directed against human sPrP also detect the shed form in brains of cattle, sheep and deer, hence in all most relevant species naturally affected by fatal and transmissible prion diseases. In human and animal prion diseases, but also in patients with Alzheimer`s disease, sPrP relocalizes from a physiological diffuse tissue pattern to intimately associate with extracellular aggregated deposits of misfolded proteins characteristic for the respective pathological condition. Findings and research tools presented here will accelerate novel insight into the roles of PrP shedding (as a process) and sPrP (as a released factor) in neurodegeneration and beyond.<\/jats:p>","DOI":"10.1007\/s00401-024-02763-5","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:02:50Z","timestamp":1720515770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases"],"prefix":"10.1007","volume":"148","author":[{"given":"Feizhi","family":"Song","sequence":"first","affiliation":[]},{"given":"Valerija","family":"Kovac","sequence":"additional","affiliation":[]},{"given":"Behnam","family":"Mohammadi","sequence":"additional","affiliation":[]},{"given":"Jessica L.","family":"Littau","sequence":"additional","affiliation":[]},{"given":"Franka","family":"Scharfenberg","sequence":"additional","affiliation":[]},{"given":"Andreu","family":"Matamoros Angles","sequence":"additional","affiliation":[]},{"given":"Ilaria","family":"Vanni","sequence":"additional","affiliation":[]},{"given":"Mohsin","family":"Shafiq","sequence":"additional","affiliation":[]},{"given":"Leonor","family":"Orge","sequence":"additional","affiliation":[]},{"given":"Giovanna","family":"Galliciotti","sequence":"additional","affiliation":[]},{"given":"Salma","family":"Djakkani","sequence":"additional","affiliation":[]},{"given":"Luise","family":"Linsenmeier","sequence":"additional","affiliation":[]},{"given":"Maja","family":"\u010cernilec","sequence":"additional","affiliation":[]},{"given":"Katrina","family":"Hartman","sequence":"additional","affiliation":[]},{"given":"Sebastian","family":"Jung","sequence":"additional","affiliation":[]},{"given":"J\u00f6rg","family":"Tatzelt","sequence":"additional","affiliation":[]},{"given":"Julia E.","family":"Neumann","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Damme","sequence":"additional","affiliation":[]},{"given":"Sarah K.","family":"Tschirner","sequence":"additional","affiliation":[]},{"given":"Stefan F.","family":"Lichtenthaler","sequence":"additional","affiliation":[]},{"given":"Franz L.","family":"Ricklefs","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Sauvigny","sequence":"additional","affiliation":[]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[]},{"given":"Berta","family":"Puig","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Tolosa","sequence":"additional","affiliation":[]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[]},{"given":"Tim","family":"Magnus","sequence":"additional","affiliation":[]},{"given":"Marjan S.","family":"Rupnik","sequence":"additional","affiliation":[]},{"given":"Diego","family":"Sepulveda-Falla","sequence":"additional","affiliation":[]},{"given":"Jakob","family":"Matschke","sequence":"additional","affiliation":[]},{"given":"Lojze M.","family":"\u0160mid","sequence":"additional","affiliation":[]},{"given":"Mara","family":"Bresjanac","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Andreoletti","sequence":"additional","affiliation":[]},{"given":"Susanne","family":"Krasemann","sequence":"additional","affiliation":[]},{"given":"Simote T.","family":"Foliaki","sequence":"additional","affiliation":[]},{"given":"Romolo","family":"Nonno","sequence":"additional","affiliation":[]},{"given":"Christoph","family":"Becker-Pauly","sequence":"additional","affiliation":[]},{"given":"Cecile","family":"Monzo","sequence":"additional","affiliation":[]},{"given":"Carole","family":"Crozet","sequence":"additional","affiliation":[]},{"given":"Cathryn L.","family":"Haigh","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[]},{"given":"Vladka","family":"Curin Serbec","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9439-6533","authenticated-orcid":false,"given":"Hermann C.","family":"Altmeppen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"2763_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00401-019-02085-x","volume":"139","author":"P Aguilar-Calvo","year":"2020","unstructured":"Aguilar-Calvo P, Sevillano AM, Bapat J, Soldau K, Sandoval DR, Altmeppen HC et al (2020) Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions. Acta Neuropathol 139:527\u2013546. https:\/\/doi.org\/10.1007\/s00401-019-02085-x","journal-title":"Acta Neuropathol"},{"key":"2763_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","volume":"31","author":"A Aguzzi","year":"2008","unstructured":"Aguzzi A, Baumann F, Bremer J (2008) The prion\u2019s elusive reason for being. Annu Rev Neurosci 31:439\u2013477. https:\/\/doi.org\/10.1146\/annurev.neuro.31.060407.125620","journal-title":"Annu Rev Neurosci"},{"key":"2763_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1152\/physrev.00006.2009","volume":"89","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi A, Calella AM (2009) Prions: protein aggregation and infectious diseases. Physiol Rev 89:1105\u20131152. https:\/\/doi.org\/10.1152\/physrev.00006.2009","journal-title":"Physiol Rev"},{"key":"2763_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04260","author":"HC Altmeppen","year":"2015","unstructured":"Altmeppen HC, Prox J, Krasemann S, Puig B, Kruszewski K, Dohler F et al (2015) The sheddase ADAM10 is a potent modulator of prion disease. Elife. https:\/\/doi.org\/10.7554\/eLife.04260","journal-title":"Elife"},{"key":"2763_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-6-36","volume":"6","author":"HC Altmeppen","year":"2011","unstructured":"Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D et al (2011) Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 6:36. https:\/\/doi.org\/10.1186\/1750-1326-6-36","journal-title":"Mol Neurodegener"},{"key":"2763_CR6","first-page":"15","volume":"1","author":"HC Altmeppen","year":"2012","unstructured":"Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, Krasemann S et al (2012) Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis 1:15\u201331","journal-title":"Am J Neurodegener Dis"},{"key":"2763_CR7","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1242\/jcs.183137","volume":"129","author":"L Amin","year":"2016","unstructured":"Amin L, Nguyen XT, Rolle IG, D\u2019Este E, Giachin G, Tran TH et al (2016) Characterization of prion protein function by focal neurite stimulation. J Cell Sci 129:3878\u20133891. https:\/\/doi.org\/10.1242\/jcs.183137","journal-title":"J Cell Sci"},{"key":"2763_CR8","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1074\/jbc.M116.773283","volume":"292","author":"BA Ballmer","year":"2017","unstructured":"Ballmer BA, Moos R, Liberali P, Pelkmans L, Hornemann S, Aguzzi A (2017) Modifiers of prion protein biogenesis and recycling identified by a highly parallel endocytosis kinetics assay. J Biol Chem 292:8356\u20138368. https:\/\/doi.org\/10.1074\/jbc.M116.773283","journal-title":"J Biol Chem"},{"key":"2763_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1471-4159.2011.07613.x","volume":"120","author":"M Beland","year":"2012","unstructured":"Beland M, Roucou X (2012) The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions. J Neurochem 120:853\u2013868. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07613.x","journal-title":"J Neurochem"},{"key":"2763_CR10","doi-asserted-by":"publisher","first-page":"23815","DOI":"10.1073\/pnas.2007406117","volume":"117","author":"I Benilova","year":"2020","unstructured":"Benilova I, Reilly M, Terry C, Wenborn A, Schmidt C, Marinho AT et al (2020) Highly infectious prions are not directly neurotoxic. Proc Natl Acad Sci USA 117:23815\u201323822. https:\/\/doi.org\/10.1073\/pnas.2007406117","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000837","volume":"6","author":"RA Bessen","year":"2010","unstructured":"Bessen RA, Shearin H, Martinka S, Boharski R, Lowe D, Wilham JM et al (2010) Prion shedding from olfactory neurons into nasal secretions. PLoS Pathog 6:e1000837. https:\/\/doi.org\/10.1371\/journal.ppat.1000837","journal-title":"PLoS Pathog"},{"key":"2763_CR12","doi-asserted-by":"publisher","first-page":"12207","DOI":"10.1073\/pnas.0404650101","volume":"101","author":"J Bieschke","year":"2004","unstructured":"Bieschke J, Weber P, Sarafoff N, Beekes M, Giese A, Kretzschmar H (2004) Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci U S A 101:12207\u201312211. https:\/\/doi.org\/10.1073\/pnas.0404650101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2763_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-020-02198-8","volume":"140","author":"BDC Boon","year":"2020","unstructured":"Boon BDC, Bulk M, Jonker AJ, Morrema THJ, van den Berg E, Popovic M et al (2020) The coarse-grained plaque: a divergent Abeta plaque-type in early-onset Alzheimer\u2019s disease. Acta Neuropathol 140:811\u2013830. https:\/\/doi.org\/10.1007\/s00401-020-02198-8","journal-title":"Acta Neuropathol"},{"key":"2763_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/glycob\/3.4.319","volume":"3","author":"DR Borchelt","year":"1993","unstructured":"Borchelt DR, Rogers M, Stahl N, Telling G, Prusiner SB (1993) Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3:319\u2013329","journal-title":"Glycobiology"},{"key":"2763_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1083\/jcb.110.3.743","volume":"110","author":"DR Borchelt","year":"1990","unstructured":"Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110:743\u2013752","journal-title":"J Cell Biol"},{"key":"2763_CR16","doi-asserted-by":"publisher","first-page":"1809065","DOI":"10.1080\/20013078.2020.1809065","volume":"9","author":"S Brenna","year":"2020","unstructured":"Brenna S, Altmeppen HC, Mohammadi B, Rissiek B, Schlink F, Ludewig P et al (2020) Characterization of brain-derived extracellular vesicles reveals changes in cellular origin after stroke and enrichment of the prion protein with a potential role in cellular uptake. J Extracell Vesicles 9:1809065. https:\/\/doi.org\/10.1080\/20013078.2020.1809065","journal-title":"J Extracell Vesicles"},{"key":"2763_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809695","author":"T Brummer","year":"2019","unstructured":"Brummer T, Muller SA, Pan-Montojo F, Yoshida F, Fellgiebel A, Tomita T et al (2019) NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer\u2019s disease. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201809695","journal-title":"EMBO Mol Med"},{"key":"2763_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/emmm.201000082","volume":"2","author":"AM Calella","year":"2010","unstructured":"Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J et al (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2:306\u2013314. https:\/\/doi.org\/10.1002\/emmm.201000082","journal-title":"EMBO Mol Med"},{"key":"2763_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209815120","volume":"120","author":"AR Castle","year":"2023","unstructured":"Castle AR, Kang SG, Eskandari-Sedighi G, Wohlgemuth S, Nguyen MA, Drucker DJ et al (2023) Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein. Proc Natl Acad Sci USA 120:e2209815120. https:\/\/doi.org\/10.1073\/pnas.2209815120","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR20","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1110837","volume":"308","author":"B Chesebro","year":"2005","unstructured":"Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R et al (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435\u20131439. https:\/\/doi.org\/10.1126\/science.1110837","journal-title":"Science"},{"key":"2763_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","volume":"24","author":"J Collinge","year":"2001","unstructured":"Collinge J (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519\u2013550","journal-title":"Annu Rev Neurosci"},{"key":"2763_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M et al (2020) PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol 139:503\u2013526. https:\/\/doi.org\/10.1007\/s00401-019-02114-9","journal-title":"Acta Neuropathol"},{"key":"2763_CR23","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1074\/jbc.M310868200","volume":"279","author":"V Curin Serbec","year":"2004","unstructured":"Curin Serbec V, Bresjanac M, Popovic M, Pretnar Hartman K, Galvani V, Rupreht R et al (2004) Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt\u2013Jacob\u2019s disease-affected and normal brain tissue. J Biol Chem 279:3694\u20133698. https:\/\/doi.org\/10.1074\/jbc.M310868200","journal-title":"J Biol Chem"},{"key":"2763_CR24","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/14737175.2021.1965882","volume":"21","author":"E Dexter","year":"2021","unstructured":"Dexter E, Kong Q (2021) Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development. Expert Rev Neurother 21:983\u2013991. https:\/\/doi.org\/10.1080\/14737175.2021.1965882","journal-title":"Expert Rev Neurother"},{"key":"2763_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/brain\/awt375","volume":"137","author":"F Dohler","year":"2014","unstructured":"Dohler F, Sepulveda-Falla D, Krasemann S, Altmeppen H, Schluter H, Hildebrand D et al (2014) High molecular mass assemblies of amyloid-beta oligomers bind prion protein in patients with Alzheimer\u2019s disease. Brain 137:873\u2013886. https:\/\/doi.org\/10.1093\/brain\/awt375","journal-title":"Brain"},{"key":"2763_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","volume":"72","author":"A Dorey","year":"2015","unstructured":"Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P et al (2015) Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt\u2013Jakob disease. JAMA Neurol 72:267\u2013275. https:\/\/doi.org\/10.1001\/jamaneurol.2014.4068","journal-title":"JAMA Neurol"},{"key":"2763_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2377-13-126","volume":"13","author":"E Dvorakova","year":"2013","unstructured":"Dvorakova E, Vranac T, Janouskova O, Cernilec M, Koren S, Lukan A et al (2013) Detection of the GPI-anchorless prion protein fragment PrP226* in human brain. BMC Neurol 13:126. https:\/\/doi.org\/10.1186\/1471-2377-13-126","journal-title":"BMC Neurol"},{"key":"2763_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.nbd.2009.07.015","volume":"36","author":"K Endres","year":"2009","unstructured":"Endres K, Mitteregger G, Kojro E, Kretzschmar H, Fahrenholz F (2009) Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis 36:233\u2013241. https:\/\/doi.org\/10.1016\/j.nbd.2009.07.015","journal-title":"Neurobiol Dis"},{"key":"2763_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jnc.13514","volume":"137","author":"C Falker","year":"2016","unstructured":"Falker C, Hartmann A, Guett I, Dohler F, Altmeppen H, Betzel C et al (2016) Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity. J Neurochem 137:88\u2013100. https:\/\/doi.org\/10.1111\/jnc.13514","journal-title":"J Neurochem"},{"key":"2763_CR30","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Miranda HV, Batalha VL, Coelho JE, Szego EM et al (2017) alpha-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci 20:1569\u20131579. https:\/\/doi.org\/10.1038\/nn.4648","journal-title":"Nat Neurosci"},{"key":"2763_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s004010000271","volume":"101","author":"I Ferrer","year":"2001","unstructured":"Ferrer I, Blanco R, Carmona M, Puig B, Ribera R, Rey MJ et al (2001) Prion protein expression in senile plaques in Alzheimer\u2019s disease. Acta Neuropathol 101:49\u201356","journal-title":"Acta Neuropathol"},{"key":"2763_CR32","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/j.1460-2075.1996.tb00467.x","volume":"15","author":"M Fischer","year":"1996","unstructured":"Fischer M, R\u00fclicke T, Raeber A, Sailer A, Moser M, Oesch B et al (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15:1255\u20131264","journal-title":"EMBO J"},{"key":"2763_CR33","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","volume":"288","author":"BR Fluharty","year":"2013","unstructured":"Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C et al (2013) An N-terminal fragment of the prion protein binds to amyloid-beta oligomers and inhibits their neurotoxicity in vivo. J Biol Chem 288:7857\u20137866. https:\/\/doi.org\/10.1074\/jbc.M112.423954","journal-title":"J Biol Chem"},{"key":"2763_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1750-3639.1996.tb00796.x","volume":"6","author":"B Ghetti","year":"1996","unstructured":"Ghetti B, Piccardo P, Frangione B, Bugiani O, Giaccone G, Young K et al (1996) Prion protein amyloidosis. Brain Pathol 6:127\u2013145","journal-title":"Brain Pathol"},{"key":"2763_CR35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1073\/pnas.93.2.744","volume":"93","author":"B Ghetti","year":"1996","unstructured":"Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F et al (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744\u2013748","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02053-5","author":"LA Gomes","year":"2019","unstructured":"Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ et al (2019) Abeta-induced acceleration of Alzheimer-related tau-pathology spreading and its association with prion protein. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02053-5","journal-title":"Acta Neuropathol"},{"key":"2763_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216084","volume":"14","author":"G Guner","year":"2022","unstructured":"Guner G, Assfalg M, Zhao K, Dreyer T, Lahiri S, Lo Y et al (2022) Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for gamma-secretase activity. EMBO Mol Med 14:e16084. https:\/\/doi.org\/10.15252\/emmm.202216084","journal-title":"EMBO Mol Med"},{"key":"2763_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112. https:\/\/doi.org\/10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2763_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1086\/605022","volume":"200","author":"DJ Haddon","year":"2009","unstructured":"Haddon DJ, Hughes MR, Antignano F, Westaway D, Cashman NR, McNagny KM (2009) Prion protein expression and release by mast cells after activation. J Infect Dis 200:827\u2013831. https:\/\/doi.org\/10.1086\/605022","journal-title":"J Infect Dis"},{"key":"2763_CR40","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1021\/bi00055a003","volume":"32","author":"DA Harris","year":"1993","unstructured":"Harris DA, Huber MT, van Dijken P, Shyng SL, Chait BT, Wang R (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 32:1009\u20131016","journal-title":"Biochemistry"},{"key":"2763_CR41","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/hmg\/11.21.2615","volume":"11","author":"D Hartmann","year":"2002","unstructured":"Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W et al (2002) The disintegrin\/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11:2615\u20132624","journal-title":"Hum Mol Genet"},{"key":"2763_CR42","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1600-0854.2008.00750.x","volume":"9","author":"A Heiseke","year":"2008","unstructured":"Heiseke A, Schobel S, Lichtenthaler SF, Vorberg I, Groschup MH, Kretzschmar H et al (2008) The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding. Traffic 9:1116\u20131129. https:\/\/doi.org\/10.1111\/j.1600-0854.2008.00750.x","journal-title":"Traffic"},{"key":"2763_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong W, Wang Z, Liu W, O\u2019Malley TT, Jin M, Willem M et al (2018) Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer\u2019s disease brain. Acta Neuropathol 136:19\u201340. https:\/\/doi.org\/10.1007\/s00401-018-1846-7","journal-title":"Acta Neuropathol"},{"key":"2763_CR44","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1073\/pnas.110523897","volume":"97","author":"M Horiuchi","year":"2000","unstructured":"Horiuchi M, Priola SA, Chabry J, Caughey B (2000) Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers [In Process Citation]. Proc Natl Acad Sci USA 97:5836\u20135841","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR45","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","volume":"102","author":"C Hundhausen","year":"2003","unstructured":"Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K et al (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186\u20131195. https:\/\/doi.org\/10.1182\/blood-2002-12-3775","journal-title":"Blood"},{"key":"2763_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-009-0609-x","volume":"119","author":"C Jansen","year":"2010","unstructured":"Jansen C, Parchi P, Capellari S, Vermeij AJ, Corrado P, Baas F et al (2010) Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 119:189\u2013197. https:\/\/doi.org\/10.1007\/s00401-009-0609-x","journal-title":"Acta Neuropathol"},{"key":"2763_CR47","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1074\/jbc.RA118.005364","volume":"294","author":"HH Jarosz-Griffiths","year":"2019","unstructured":"Jarosz-Griffiths HH, Corbett NJ, Rowland HA, Fisher K, Jones AC, Baron J et al (2019) Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-beta oligomers. J Biol Chem 294:7085\u20137097. https:\/\/doi.org\/10.1074\/jbc.RA118.005364","journal-title":"J Biol Chem"},{"key":"2763_CR48","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0002-9440(10)65744-6","volume":"153","author":"A Jimenez-Huete","year":"1998","unstructured":"Jimenez-Huete A, Lievens PM, Vidal R, Piccardo P, Ghetti B, Tagliavini F et al (1998) Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153:1561\u20131572. https:\/\/doi.org\/10.1016\/S0002-9440(10)65744-6","journal-title":"Am J Pathol"},{"key":"2763_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154305","volume":"23","author":"G Jocher","year":"2022","unstructured":"Jocher G, Grass V, Tschirner SK, Riepler L, Breimann S, Kaya T et al (2022) ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion. EMBO Rep 23:e54305. https:\/\/doi.org\/10.15252\/embr.202154305","journal-title":"EMBO Rep"},{"key":"2763_CR50","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1523\/JNEUROSCI.5221-09.2010","volume":"30","author":"E Jorissen","year":"2010","unstructured":"Jorissen E, Prox J, Bernreuther C, Weber S, Schwanbeck R, Serneels L et al (2010) The disintegrin\/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci 30:4833\u20134844. https:\/\/doi.org\/10.1523\/JNEUROSCI.5221-09.2010","journal-title":"J Neurosci"},{"key":"2763_CR51","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1074\/jbc.RA120.013444","volume":"295","author":"A Kobayashi","year":"2020","unstructured":"Kobayashi A, Hirata T, Nishikaze T, Ninomiya A, Maki Y, Takada Y et al (2020) alpha2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein. J Biol Chem 295:7789\u20137798. https:\/\/doi.org\/10.1074\/jbc.RA120.013444","journal-title":"J Biol Chem"},{"key":"2763_CR52","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1523\/JNEUROSCI.5126-08.2009","volume":"29","author":"ZA Kohutek","year":"2009","unstructured":"Kohutek ZA, diPierro CG, Redpath GT, Hussaini IM (2009) ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration. J Neurosci 29:4605\u20134615. https:\/\/doi.org\/10.1523\/JNEUROSCI.5126-08.2009","journal-title":"J Neurosci"},{"key":"2763_CR53","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1038\/s41598-023-30202-0","volume":"13","author":"K Kopycka","year":"2023","unstructured":"Kopycka K, Maddison BC, Gough KC (2023) Recombinant ovine prion protein can be mutated at position 136 to improve its efficacy as an inhibitor of prion propagation. Sci Rep 13:3452. https:\/\/doi.org\/10.1038\/s41598-023-30202-0","journal-title":"Sci Rep"},{"key":"2763_CR54","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.molimm.2010.11.012","volume":"48","author":"M Kosmac","year":"2011","unstructured":"Kosmac M, Koren S, Giachin G, Stoilova T, Gennaro R, Legname G et al (2011) Epitope mapping of a PrP(Sc)-specific monoclonal antibody: identification of a novel C-terminally truncated prion fragment. Mol Immunol 48:746\u2013750. https:\/\/doi.org\/10.1016\/j.molimm.2010.11.012","journal-title":"Mol Immunol"},{"key":"2763_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031232","author":"V Kovac","year":"2022","unstructured":"Kovac V, Curin Serbec V (2022) Prion protein: the molecule of many forms and faces. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031232","journal-title":"Int J Mol Sci"},{"key":"2763_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2016.11.036","volume":"481","author":"V Kovac","year":"2016","unstructured":"Kovac V, Hafner-Bratkovic I, Curin Serbec V (2016) Anchorless forms of prion protein\u2014impact of truncation on structure destabilization and prion protein conversion. Biochem Biophys Res Commun 481:1\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.036","journal-title":"Biochem Biophys Res Commun"},{"key":"2763_CR57","doi-asserted-by":"publisher","DOI":"10.1177\/1177271918756648","author":"V Kovac","year":"2018","unstructured":"Kovac V, Serbec VC (2018) Prion proteins without the glycophosphatidylinositol anchor: potential biomarkers in neurodegenerative diseases. Biomark Insights. https:\/\/doi.org\/10.1177\/1177271918756648","journal-title":"Biomark Insights"},{"key":"2763_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrc.2017.01.078","volume":"484","author":"V Kovac","year":"2017","unstructured":"Kovac V, Zupancic B, Ilc G, Plavec J, Curin Serbec V (2017) Truncated prion protein PrP226*\u2014a structural view on its role in amyloid disease. Biochem Biophys Res Commun 484:45\u201350. https:\/\/doi.org\/10.1016\/j.bbrc.2017.01.078","journal-title":"Biochem Biophys Res Commun"},{"key":"2763_CR59","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature19312","volume":"536","author":"A Kuffer","year":"2016","unstructured":"Kuffer A, Lakkaraju AK, Mogha A, Petersen SC, Airich K, Doucerain C et al (2016) The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6. Nature 536:464\u2013468. https:\/\/doi.org\/10.1038\/nature19312","journal-title":"Nature"},{"key":"2763_CR60","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/emboj.2010.167","volume":"29","author":"PH Kuhn","year":"2010","unstructured":"Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW et al (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 29:3020\u20133032. https:\/\/doi.org\/10.1038\/emboj.2010.167","journal-title":"EMBO J"},{"key":"2763_CR61","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1016\/j.febslet.2005.10.013","volume":"579","author":"I Laffont-Proust","year":"2005","unstructured":"Laffont-Proust I, Faucheux BA, Hassig R, Sazdovitch V, Simon S, Grassi J et al (2005) The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett 579:6333\u20136337. https:\/\/doi.org\/10.1016\/j.febslet.2005.10.013","journal-title":"FEBS Lett"},{"key":"2763_CR62","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448\u20136453","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR63","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA (2014) Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 9:2329\u20132340. https:\/\/doi.org\/10.1038\/nprot.2014.158","journal-title":"Nat Protoc"},{"key":"2763_CR64","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457:1128\u20131132. https:\/\/doi.org\/10.1038\/nature07761","journal-title":"Nature"},{"key":"2763_CR65","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1038\/s41596-019-0212-0","volume":"14","author":"YK Lee","year":"2019","unstructured":"Lee YK, Uchida H, Smith H, Ito A, Sanchez T (2019) The isolation and molecular characterization of cerebral microvessels. Nat Protoc 14:3059\u20133081. https:\/\/doi.org\/10.1038\/s41596-019-0212-0","journal-title":"Nat Protoc"},{"key":"2763_CR66","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00018-015-2022-z","volume":"73","author":"V Lewis","year":"2016","unstructured":"Lewis V, Johanssen VA, Crouch PJ, Klug GM, Hooper NM, Collins SJ (2016) Prion protein \u201cgamma-cleavage\u201d: characterizing a novel endoproteolytic processing event. Cell Mol Life Sci 73:667\u2013683. https:\/\/doi.org\/10.1007\/s00018-015-2022-z","journal-title":"Cell Mol Life Sci"},{"key":"2763_CR67","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899456","author":"SF Lichtenthaler","year":"2018","unstructured":"Lichtenthaler SF, Lemberg MK, Fluhrer R (2018) Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments. EMBO J. https:\/\/doi.org\/10.15252\/embj.201899456","journal-title":"EMBO J"},{"key":"2763_CR68","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.conb.2021.09.003","volume":"72","author":"SF Lichtenthaler","year":"2022","unstructured":"Lichtenthaler SF, Tschirner SK, Steiner H (2022) Secretases in Alzheimer\u2019s disease: novel insights into proteolysis of APP and TREM2. Curr Opin Neurobiol 72:101\u2013110. https:\/\/doi.org\/10.1016\/j.conb.2021.09.003","journal-title":"Curr Opin Neurobiol"},{"key":"2763_CR69","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00018-011-0847-7","volume":"69","author":"R Linden","year":"2012","unstructured":"Linden R, Cordeiro Y, Lima LM (2012) Allosteric function and dysfunction of the prion protein. Cell Mol Life Sci 69:1105\u20131124. https:\/\/doi.org\/10.1007\/s00018-011-0847-7","journal-title":"Cell Mol Life Sci"},{"key":"2763_CR70","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.bbamcr.2017.06.022","volume":"1864","author":"L Linsenmeier","year":"2017","unstructured":"Linsenmeier L, Altmeppen HC, Wetzel S, Mohammadi B, Saftig P, Glatzel M (2017) Diverse functions of the prion protein\u2014does proteolytic processing hold the key? Biochim Biophys Acta 1864:2128\u20132137. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.06.022","journal-title":"Biochim Biophys Acta"},{"key":"2763_CR71","doi-asserted-by":"publisher","first-page":"eabj1826","DOI":"10.1126\/sciadv.abj1826","volume":"7","author":"L Linsenmeier","year":"2021","unstructured":"Linsenmeier L, Mohammadi B, Shafiq M, Frontzek K, Bar J, Shrivastava AN et al (2021) Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies. Sci Adv 7:eabj1826. https:\/\/doi.org\/10.1126\/sciadv.abj1826","journal-title":"Sci Adv"},{"key":"2763_CR72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-018-0248-6","volume":"13","author":"L Linsenmeier","year":"2018","unstructured":"Linsenmeier L, Mohammadi B, Wetzel S, Puig B, Jackson WS, Hartmann A et al (2018) Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein. Mol Neurodegener 13:18. https:\/\/doi.org\/10.1186\/s13024-018-0248-6","journal-title":"Mol Neurodegener"},{"key":"2763_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.06.026","author":"CH Lipper","year":"2023","unstructured":"Lipper CH, Egan ED, Gabriel KH, Blacklow SC (2023) Structural basis for membrane-proximal proteolysis of substrates by ADAM10. Cell. https:\/\/doi.org\/10.1016\/j.cell.2023.06.026","journal-title":"Cell"},{"key":"2763_CR74","doi-asserted-by":"publisher","first-page":"W249","DOI":"10.1093\/nar\/gkr431","volume":"39","author":"N London","year":"2011","unstructured":"London N, Raveh B, Cohen E, Fathi G, Schueler-Furman O (2011) Rosetta FlexPepDock web server\u2013high resolution modeling of peptide-protein interactions. Nucleic Acids Res 39:W249-253. https:\/\/doi.org\/10.1093\/nar\/gkr431","journal-title":"Nucleic Acids Res"},{"key":"2763_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/pri.28388","volume":"8","author":"A Lukan","year":"2014","unstructured":"Lukan A, Cernilec M, Vranac T, Popovic M, Curin Serbec V (2014) Regional distribution of anchorless prion protein, PrP226*, in the human brain. Prion 8:203\u2013209. https:\/\/doi.org\/10.4161\/pri.28388","journal-title":"Prion"},{"key":"2763_CR76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1423-0410.1999.7720088.x","volume":"77","author":"I MacGregor","year":"1999","unstructured":"MacGregor I, Hope J, Barnard G, Kirby L, Drummond O, Pepper D et al (1999) Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sang 77:88\u201396","journal-title":"Vox Sang"},{"key":"2763_CR77","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00441-022-03676-z","volume":"392","author":"SW Manka","year":"2023","unstructured":"Manka SW, Wenborn A, Collinge J, Wadsworth JDF (2023) Prion strains viewed through the lens of cryo-EM. Cell Tissue Res 392:167\u2013178. https:\/\/doi.org\/10.1007\/s00441-022-03676-z","journal-title":"Cell Tissue Res"},{"key":"2763_CR78","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1074\/jbc.RA120.013779","volume":"295","author":"E Mantuano","year":"2020","unstructured":"Mantuano E, Azmoon P, Banki MA, Lam MS, Sigurdson CJ, Gonias SL (2020) A soluble derivative of PrP(C) activates cell-signaling and regulates cell physiology through LRP1 and the NMDA receptor. J Biol Chem 295:14178\u201314188. https:\/\/doi.org\/10.1074\/jbc.RA120.013779","journal-title":"J Biol Chem"},{"key":"2763_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4049\/jimmunol.2100412","volume":"208","author":"E Mantuano","year":"2022","unstructured":"Mantuano E, Azmoon P, Banki MA, Sigurdson CJ, Campana WM, Gonias SL (2022) A Soluble PrP(C) derivative and membrane-anchored PrP(C) in extracellular vesicles attenuate innate immunity by engaging the NMDA-R\/LRP1 receptor complex. J Immunol 208:85\u201396. https:\/\/doi.org\/10.4049\/jimmunol.2100412","journal-title":"J Immunol"},{"key":"2763_CR80","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170121","author":"E Mantuano","year":"2023","unstructured":"Mantuano E, Zampieri C, Azmoon P, Gunner CB, Heye KR, Gonias SL (2023) An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length protein. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.170121","journal-title":"JCI Insight"},{"key":"2763_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020345","author":"S Martellucci","year":"2019","unstructured":"Martellucci S, Santacroce C, Santilli F, Piccoli L, Delle Monache S, Angelucci A et al (2019) Cellular and molecular mechanisms mediated by recPrP(C) involved in the neuronal differentiation process of mesenchymal stem cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20020345","journal-title":"Int J Mol Sci"},{"key":"2763_CR82","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1126\/science.1132661","volume":"314","author":"CK Mathiason","year":"2006","unstructured":"Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, Warren RJ et al (2006) Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314:133\u2013136. https:\/\/doi.org\/10.1126\/science.1132661","journal-title":"Science"},{"key":"2763_CR83","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1074\/jbc.M113.502351","volume":"289","author":"AJ McDonald","year":"2014","unstructured":"McDonald AJ, Dibble JP, Evans EG, Millhauser GL (2014) A new paradigm for enzymatic control of alpha-cleavage and beta-cleavage of the prion protein. J Biol Chem 289:803\u2013813. https:\/\/doi.org\/10.1074\/jbc.M113.502351","journal-title":"J Biol Chem"},{"key":"2763_CR84","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1056\/NEJMoa1214747","volume":"369","author":"S Mead","year":"2013","unstructured":"Mead S, Gandhi S, Beck J, Caine D, Gallujipali D, Carswell C et al (2013) A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med 369:1904\u20131914","journal-title":"N Engl J Med"},{"key":"2763_CR85","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1474-4422(22)00082-5","volume":"21","author":"S Mead","year":"2022","unstructured":"Mead S, Khalili-Shirazi A, Potter C, Mok T, Nihat A, Hyare H et al (2022) Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt\u2013Jakob disease: evaluation of a first-in-human treatment programme. Lancet Neurol 21:342\u2013354. https:\/\/doi.org\/10.1016\/S1474-4422(22)00082-5","journal-title":"Lancet Neurol"},{"key":"2763_CR86","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4049\/jimmunol.1601041","volume":"199","author":"BW Megra","year":"2017","unstructured":"Megra BW, Eugenin EA, Berman JW (2017) The role of shed PrPc in the neuropathogenesis of HIV infection. J Immunol 199:224\u2013232. https:\/\/doi.org\/10.4049\/jimmunol.1601041","journal-title":"J Immunol"},{"key":"2763_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270915","volume":"17","author":"M Mehrabian","year":"2022","unstructured":"Mehrabian M, Wang X, Eid S, Yan BQ, Grinberg M, Siegner M et al (2022) Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein. PLoS ONE 17:e0270915. https:\/\/doi.org\/10.1371\/journal.pone.0270915","journal-title":"PLoS ONE"},{"key":"2763_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0092-8674(03)00201-0","volume":"113","author":"P Meier","year":"2003","unstructured":"Meier P, Genoud N, Prinz M, Maissen M, Rulicke T, Zurbriggen A et al (2003) Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell 113:49\u201360","journal-title":"Cell"},{"key":"2763_CR89","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3233\/JAD-2009-1110","volume":"17","author":"F Meyne","year":"2009","unstructured":"Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B et al (2009) Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 17:863\u2013873. https:\/\/doi.org\/10.3233\/JAD-2009-1110","journal-title":"J Alzheimers Dis"},{"key":"2763_CR90","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1074\/mcp.RA119.001702","volume":"18","author":"EV Minikel","year":"2019","unstructured":"Minikel EV, Kuhn E, Cocco AR, Vallabh SM, Hartigan CR, Reidenbach AG et al (2019) Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry. Mol Cell Proteom 18:2388\u20132400. https:\/\/doi.org\/10.1074\/mcp.RA119.001702","journal-title":"Mol Cell Proteom"},{"key":"2763_CR91","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","volume":"48","author":"EV Minikel","year":"2020","unstructured":"Minikel EV, Zhao HT, Le J, O\u2019Moore J, Pitstick R, Graffam S et al (2020) Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Res 48:10615\u201310631. https:\/\/doi.org\/10.1093\/nar\/gkaa616","journal-title":"Nucleic Acids Res"},{"key":"2763_CR92","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1007\/s12035-020-01917-2","volume":"57","author":"B Mohammadi","year":"2020","unstructured":"Mohammadi B, Linsenmeier L, Shafiq M, Puig B, Galliciotti G, Giudici C et al (2020) Transgenic overexpression of the disordered prion protein N1 fragment in mice does not protect against neurodegenerative diseases due to impaired ER translocation. Mol Neurobiol 57:2812\u20132829. https:\/\/doi.org\/10.1007\/s12035-020-01917-2","journal-title":"Mol Neurobiol"},{"key":"2763_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-022-03582-4","author":"B Mohammadi","year":"2022","unstructured":"Mohammadi B, Song F, Matamoros-Angles A, Shafiq M, Damme M, Puig B et al (2022) Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-022-03582-4","journal-title":"Cell Tissue Res"},{"key":"2763_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad371","author":"MA Mortberg","year":"2023","unstructured":"Mortberg MA, Gentile JE, Nadaf NM, Vanderburg C, Simmons S, Dubinsky D et al (2023) A single-cell map of antisense oligonucleotide activity in the brain. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkad371","journal-title":"Nucleic Acids Res"},{"key":"2763_CR95","doi-asserted-by":"publisher","first-page":"33104","DOI":"10.1074\/jbc.C112.400614","volume":"287","author":"K Nieznanski","year":"2012","unstructured":"Nieznanski K, Choi JK, Chen S, Surewicz K, Surewicz WK (2012) Soluble prion protein inhibits amyloid-beta (abeta) fibrillization and toxicity. J Biol Chem 287:33104\u201333108. https:\/\/doi.org\/10.1074\/jbc.C112.400614","journal-title":"J Biol Chem"},{"key":"2763_CR96","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.1523\/JNEUROSCI.1700-18.2018","volume":"38","author":"T Ondrejcak","year":"2018","unstructured":"Ondrejcak T, Klyubin I, Corbett GT, Fraser G, Hong W, Mably AJ et al (2018) Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo. J Neurosci 38:10595\u201310606. https:\/\/doi.org\/10.1523\/JNEUROSCI.1700-18.2018","journal-title":"J Neurosci"},{"key":"2763_CR97","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00401-008-0394-y","volume":"116","author":"C Paquet","year":"2008","unstructured":"Paquet C, Privat N, Kaci R, Polivka M, Dupont O, Haik S et al (2008) Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt\u2013Jakob disease. Acta Neuropathol 116:567\u2013573. https:\/\/doi.org\/10.1007\/s00401-008-0394-y","journal-title":"Acta Neuropathol"},{"key":"2763_CR98","doi-asserted-by":"publisher","first-page":"44627","DOI":"10.1074\/jbc.M107458200","volume":"276","author":"P Parizek","year":"2001","unstructured":"Parizek P, Roeckl C, Weber J, Flechsig E, Aguzzi A, Raeber AJ (2001) Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem 276:44627\u201344632. https:\/\/doi.org\/10.1074\/jbc.M107458200","journal-title":"J Biol Chem"},{"key":"2763_CR99","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0140-6736(96)91128-9","volume":"347","author":"F Perini","year":"1996","unstructured":"Perini F, Frangione B, Prelli F (1996) Prion protein released by platelets. Lancet 347:1635\u20131636","journal-title":"Lancet"},{"key":"2763_CR100","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/00005072-199511000-00006","volume":"54","author":"P Piccardo","year":"1995","unstructured":"Piccardo P, Ghetti B, Dickson DW, Vinters HV, Giaccone G, Bugiani O et al (1995) Gerstmann\u2013Straussler\u2013Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90\u2013165. J Neuropathol Exp Neurol 54:790\u2013801","journal-title":"J Neuropathol Exp Neurol"},{"key":"2763_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.200","author":"L Provenzano","year":"2017","unstructured":"Provenzano L, Ryan Y, Hilton DA, Lyons-Rimmer J, Dave F, Maze EA et al (2017) Cellular prion protein (PrPC) in the development of Merlin-deficient tumours. Oncogene. https:\/\/doi.org\/10.1038\/onc.2017.200","journal-title":"Oncogene"},{"issue":"12915\u201312928","key":"2763_CR102","doi-asserted-by":"publisher","first-page":"12928a","DOI":"10.1523\/JNEUROSCI.5910-12.2013","volume":"33","author":"J Prox","year":"2013","unstructured":"Prox J, Bernreuther C, Altmeppen H, Grendel J, Glatzel M, D\u2019Hooge R et al (2013) Postnatal disruption of the disintegrin\/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci 33(12915\u201312928):12928a. https:\/\/doi.org\/10.1523\/JNEUROSCI.5910-12.2013","journal-title":"J Neurosci"},{"key":"2763_CR103","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136\u2013144","journal-title":"Science"},{"key":"2763_CR104","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131175","author":"GJ Raymond","year":"2019","unstructured":"Raymond GJ, Zhao HT, Race B, Raymond LD, Williams K, Swayze EE et al (2019) Antisense oligonucleotides extend survival of prion-infected mice. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.131175","journal-title":"JCI Insight"},{"key":"2763_CR105","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/emboj.2011.86","volume":"30","author":"UK Resenberger","year":"2011","unstructured":"Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Muller V, Krishnan R et al (2011) The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J 30:2057\u20132070. https:\/\/doi.org\/10.1038\/emboj.2011.86","journal-title":"EMBO J"},{"key":"2763_CR106","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2353\/ajpath.2010.091006","volume":"177","author":"TK Roberts","year":"2010","unstructured":"Roberts TK, Eugenin EA, Morgello S, Clements JE, Zink MC, Berman JW (2010) PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am J Pathol 177:1848\u20131860. https:\/\/doi.org\/10.2353\/ajpath.2010.091006","journal-title":"Am J Pathol"},{"key":"2763_CR107","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16870","author":"D Rosenbaum","year":"2023","unstructured":"Rosenbaum D, Saftig P (2023) New insights into the function and pathophysiology of the ectodomain sheddase A disintegrin and metalloproteinase 10 (ADAM10). FEBS J. https:\/\/doi.org\/10.1111\/febs.16870","journal-title":"FEBS J"},{"key":"2763_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2015.10.003","author":"P Saftig","year":"2015","unstructured":"Saftig P, Lichtenthaler SF (2015) The alpha secretase ADAM10: a metalloprotease with multiple functions in the brain. Prog Neurobiol. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.10.003","journal-title":"Prog Neurobiol"},{"key":"2763_CR109","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature09768","volume":"470","author":"MK Sandberg","year":"2011","unstructured":"Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470:540\u2013542. https:\/\/doi.org\/10.1038\/nature09768","journal-title":"Nature"},{"key":"2763_CR110","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00018-019-03184-4","volume":"77","author":"F Scharfenberg","year":"2020","unstructured":"Scharfenberg F, Helbig A, Sammel M, Benzel J, Schlomann U, Peters F et al (2020) Degradome of soluble ADAM10 and ADAM17 metalloproteases. Cell Mol Life Sci 77:331\u2013350. https:\/\/doi.org\/10.1007\/s00018-019-03184-4","journal-title":"Cell Mol Life Sci"},{"issue":"Pt 1","key":"2763_CR111","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/bj3470131","volume":"347","author":"J Schlondorff","year":"2000","unstructured":"Schlondorff J, Becherer JD, Blobel CP (2000) Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 347(Pt 1):131\u2013138","journal-title":"Biochem J"},{"key":"2763_CR112","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2004.10.004","volume":"26","author":"K Schwarze-Eicker","year":"2005","unstructured":"Schwarze-Eicker K, Keyvani K, Gortz N, Westaway D, Sachser N, Paulus W (2005) Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiol Aging 26:1177\u20131182","journal-title":"Neurobiol Aging"},{"key":"2763_CR113","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.nbd.2016.03.001","volume":"91","author":"JJ Scott-McKean","year":"2016","unstructured":"Scott-McKean JJ, Surewicz K, Choi JK, Ruffin VA, Salameh AI, Nieznanski K et al (2016) Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Abeta oligomers: Implications for novel therapeutic strategy in Alzheimer\u2019s disease. Neurobiol Dis 91:124\u2013131. https:\/\/doi.org\/10.1016\/j.nbd.2016.03.001","journal-title":"Neurobiol Dis"},{"issue":"1638\u20131648","key":"2763_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.11.014","volume":"171","author":"TCM Seegar","year":"2017","unstructured":"Seegar TCM, Killingsworth LB, Saha N, Meyer PA, Patra D, Zimmerman B et al (2017) Structural basis for regulated proteolysis by the alpha-secretase ADAM10. Cell 171(1638\u20131648):e1637. https:\/\/doi.org\/10.1016\/j.cell.2017.11.014","journal-title":"Cell"},{"key":"2763_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2791-2","author":"L Seipold","year":"2018","unstructured":"Seipold L, Altmeppen H, Koudelka T, Tholey A, Kasparek P, Sedlacek R et al (2018) In vivo regulation of the A disintegrin and metalloproteinase 10 (ADAM10) by the tetraspanin 15. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-018-2791-2","journal-title":"Cell Mol Life Sci"},{"key":"2763_CR116","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI131564","volume":"130","author":"AM Sevillano","year":"2020","unstructured":"Sevillano AM, Aguilar-Calvo P, Kurt TD, Lawrence JA, Soldau K, Nam TH et al (2020) Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease. J Clin Invest 130:1350\u20131362. https:\/\/doi.org\/10.1172\/JCI131564","journal-title":"J Clin Invest"},{"key":"2763_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015783","volume":"6","author":"N Skrlj","year":"2011","unstructured":"Skrlj N, Vranac T, Popovic M, Curin Serbec V, Dolinar M (2011) Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment. PLoS ONE 6:e15783. https:\/\/doi.org\/10.1371\/journal.pone.0015783","journal-title":"PLoS ONE"},{"key":"2763_CR118","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1021\/bi00474a028","volume":"29","author":"N Stahl","year":"1990","unstructured":"Stahl N, Borchelt DR, Prusiner SB (1990) Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 29:5405\u20135412","journal-title":"Biochemistry"},{"key":"2763_CR119","doi-asserted-by":"publisher","first-page":"21223","DOI":"10.1073\/pnas.1117827108","volume":"108","author":"J Stohr","year":"2011","unstructured":"Stohr J, Watts JC, Legname G, Oehler A, Lemus A, Nguyen HO et al (2011) Spontaneous generation of anchorless prions in transgenic mice. Proc Natl Acad Sci USA 108:21223\u201321228. https:\/\/doi.org\/10.1073\/pnas.1117827108","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR120","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/S0006-291X(05)80038-5","volume":"184","author":"F Tagliavini","year":"1992","unstructured":"Tagliavini F, Prelli F, Porro M, Salmona M, Bugiani O, Frangione B (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun 184:1398\u20131404","journal-title":"Biochem Biophys Res Commun"},{"key":"2763_CR121","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12941","author":"RH Takahashi","year":"2021","unstructured":"Takahashi RH, Yokotsuka M, Tobiume M, Sato Y, Hasegawa H, Nagao T et al (2021) Accumulation of cellular prion protein within beta-amyloid oligomer plaques in aged human brains. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12941","journal-title":"Brain Pathol"},{"key":"2763_CR122","doi-asserted-by":"publisher","first-page":"22590","DOI":"10.1074\/jbc.M109.032599","volume":"284","author":"DR Taylor","year":"2009","unstructured":"Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ et al (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 284:22590\u201322600. https:\/\/doi.org\/10.1074\/jbc.M109.032599","journal-title":"J Biol Chem"},{"key":"2763_CR123","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1126\/science.274.5295.2079","volume":"274","author":"GC Telling","year":"1996","unstructured":"Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079\u20132082","journal-title":"Science"},{"key":"2763_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227094","volume":"15","author":"JM Tennant","year":"2020","unstructured":"Tennant JM, Li M, Henderson DM, Tyer ML, Denkers ND, Haley NJ et al (2020) Shedding and stability of CWD prion seeding activity in cervid feces. PLoS ONE 15:e0227094. https:\/\/doi.org\/10.1371\/journal.pone.0227094","journal-title":"PLoS ONE"},{"key":"2763_CR125","doi-asserted-by":"publisher","first-page":"W288","DOI":"10.1093\/nar\/gks419","volume":"40","author":"P Thevenet","year":"2012","unstructured":"Thevenet P, Shen Y, Maupetit J, Guyon F, Derreumaux P, Tuffery P (2012) PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res 40:W288-293. https:\/\/doi.org\/10.1093\/nar\/gks419","journal-title":"Nucleic Acids Res"},{"key":"2763_CR126","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/14737159.2019.1667231","volume":"19","author":"K Thune","year":"2019","unstructured":"Thune K, Schmitz M, Villar-Pique A, Altmeppen HC, Schlomm M, Zafar S et al (2019) The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers. Expert Rev Mol Diagn 19:1007\u20131018. https:\/\/doi.org\/10.1080\/14737159.2019.1667231","journal-title":"Expert Rev Mol Diagn"},{"key":"2763_CR127","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1021\/pr401135u","volume":"13","author":"J Tucher","year":"2014","unstructured":"Tucher J, Linke D, Koudelka T, Cassidy L, Tredup C, Wichert R et al (2014) LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. J Proteome Res 13:2205\u20132214. https:\/\/doi.org\/10.1021\/pr401135u","journal-title":"J Proteome Res"},{"key":"2763_CR128","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.bbrc.2006.04.046","volume":"344","author":"NP Ulrih","year":"2006","unstructured":"Ulrih NP, Skrt M, Veranic P, Galvani V, Vranac T, Curin Serbec V (2006) Oligomeric forms of peptide fragment PrP(214\u2013226) in solution are preferentially recognized by PrP(Sc)-specific antibody. Biochem Biophys Res Commun 344:1320\u20131326. https:\/\/doi.org\/10.1016\/j.bbrc.2006.04.046","journal-title":"Biochem Biophys Res Commun"},{"key":"2763_CR129","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1073\/pnas.1901947116","volume":"116","author":"SM Vallabh","year":"2019","unstructured":"Vallabh SM, Nobuhara CK, Llorens F, Zerr I, Parchi P, Capellari S et al (2019) Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. Proc Natl Acad Sci USA 116:7793\u20137798. https:\/\/doi.org\/10.1073\/pnas.1901947116","journal-title":"Proc Natl Acad Sci USA"},{"key":"2763_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102823","volume":"299","author":"I Vanni","year":"2022","unstructured":"Vanni I, Iacobone F, D\u2019Agostino C, Giovannelli M, Pirisinu L, Altmeppen HC et al (2022) An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein. J Biol Chem 299:102823. https:\/\/doi.org\/10.1016\/j.jbc.2022.102823","journal-title":"J Biol Chem"},{"key":"2763_CR131","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129:183\u2013206. https:\/\/doi.org\/10.1007\/s00401-015-1386-3","journal-title":"Acta Neuropathol"},{"key":"2763_CR132","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.peptides.2006.05.026","volume":"27","author":"T Vranac","year":"2006","unstructured":"Vranac T, Hartman KP, Popovic M, Venturini A, Zerovnik E, Curin Serbec V (2006) A single prion protein peptide can elicit a panel of isoform specific monoclonal antibodies. Peptides 27:2695\u20132705. https:\/\/doi.org\/10.1016\/j.peptides.2006.05.026","journal-title":"Peptides"},{"key":"2763_CR133","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539. https:\/\/doi.org\/10.1038\/416535a","journal-title":"Nature"},{"key":"2763_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2017.06.005","author":"S Wetzel","year":"2017","unstructured":"Wetzel S, Seipold L, Saftig P (2017) The metalloproteinase ADAM10: a useful therapeutic target? Biochim Biophys Acta. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.06.005","journal-title":"Biochim Biophys Acta"},{"key":"2763_CR135","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124092","author":"AP Wiegmans","year":"2019","unstructured":"Wiegmans AP, Saunus JM, Ham S, Lobb R, Kutasovic JR, Dalley AJ et al (2019) Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.124092","journal-title":"JCI Insight"},{"key":"2763_CR136","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1038\/srep02911","volume":"3","author":"J Yuan","year":"2013","unstructured":"Yuan J, Zhan YA, Abskharon R, Xiao X, Martinez MC, Zhou X et al (2013) Recombinant human prion protein inhibits prion propagation in vitro. Sci Rep 3:2911. https:\/\/doi.org\/10.1038\/srep02911","journal-title":"Sci Rep"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02763-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02763-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T09:05:34Z","timestamp":1720515934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02763-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2763"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02763-5","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Use of human and animal samples was in agreement with respective international and institutional guidelines as well as local regulations. This work was covered by respective approvals of responsible local authorities as mentioned in detail in the methods section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"2"}}